Treatment | Overall cohort (n=379) | Organ-confined cohort (n=251) | FFbF analysis cohort (n=52) |
---|---|---|---|
n (%) | n (%) | n (%) | |
EBRT | 147 (38.8) | 141 (56.2) | 52 (100.0) |
EBRT alone | 20 (5.3) | 18 (7.2) | 4 (7.7) |
EBRT + ADT | 121 (31.9) | 117 (46.6) | 48 (92.3) |
EBRT + Brachytherapy | 2 (0.5) | 2 (0.8) | -- |
EBRT+ADT+ Brachytherapy | 4 (1.1) | 4 (1.6) | -- |
ADT alone | 139 (36.7) | 60 (23.9) | -- |
LHRH agonist | 120 (31.7) | 58 (23.1) | -- |
Orchiectomy | 38 (10.0) | 9 (3.6) | -- |
Brachytherapy alone | 13 (3.4) | 13 (5.2) | -- |